Stage I - II primary lung cancer
Showing 1 - 25 of >10,000
Stage I - II Primary Lung Cancer, Stage I Lung Cancer, Stage II Lung Cancer Trial in Boston (AveCure 16 Gauge Flexible Microwave
Not yet recruiting
- Stage I - II Primary Lung Cancer
- +5 more
- AveCure 16 Gauge Flexible Microwave Ablation Probe
-
Boston, MassachusettsBeth Israel Deaconess Medical Center
Mar 11, 2022
Lung Carcinoma, Lung Non-Small Cell Carcinoma, Metastatic Malignant Tumor in the Lung Trial in Chicago (procedure, other,
Not yet recruiting
- Lung Carcinoma
- +5 more
- Computed Tomography
- +6 more
-
Chicago, IllinoisNorthwestern University
Mar 24, 2023
NSCLC, Stage IV, Oligometastasis Trial in Netherlands, Spain, Switzerland (drug, radiation, procedure)
Active, not recruiting
- Non-small Cell Lung Cancer
- +2 more
- Durvalumab
- +6 more
-
Milano, Italy
- +12 more
Dec 14, 2022
Limited Stage Lung Small Cell Carcinoma, Stage I Lung Cancer, Stage II Lung Cancer Trial in Nashville (drug, biological,
Not yet recruiting
- Limited Stage Lung Small Cell Carcinoma
- +3 more
- Cisplatin
- +8 more
-
Nashville, TennesseeVanderbilt University/Ingram Cancer Center
Nov 10, 2023
Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8 Trial
Recruiting
- Anatomic Stage I Breast Cancer AJCC v8
- +6 more
- Biopsy
- +3 more
-
Jacksonville, FloridaMayo Clinic in Florida
Jan 6, 2023
Extensive Stage Lung Small Cell Carcinoma, Stage IV Lung Cancer Trial in Nashville (drug, biological, radiation, procedure)
Not yet recruiting
- Extensive Stage Lung Small Cell Carcinoma
- Stage IV Lung Cancer
- Carboplatin
- +5 more
-
Nashville, TennesseeVanderbilt University/Ingram Cancer Center
Oct 25, 2023
Lung Cancer, Carcinoma, Non-Small Cell Lung Trial in Omaha (consolidative hypofractionated radiation therapy (hfRT), Durvalumab
Recruiting
- Lung Cancer
- Carcinoma, Non-Small Cell Lung
- consolidative hypofractionated radiation therapy (hfRT)
- Durvalumab 50 MG/ML
-
Omaha, NebraskaUniversity of Nebraska Medical Center
Jul 27, 2021
Sarcoma, Synovial, Sarcoma,Soft Tissue, Melanoma Stage IV Trial in Jerusalem (CYCLOPHOSPHAMIDE and FLUDARABIN, Cyclophosphamide,
Recruiting
- Sarcoma, Synovial
- +8 more
- CYCLOPHOSPHAMIDE and FLUDARABIN
- +3 more
-
Jerusalem, IsraelHadassah Medical Organization
Mar 15, 2022
Caregiver, Lung Non-Small Cell Carcinoma, Stage I Lung Cancer AJCC v8 Trial in Houston (Educational Intervention,
Recruiting
- Esophageal Carcinoma
- +16 more
- Educational Intervention
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Nov 11, 2022
Lung Cancer, Metastatic Cancer Trial in Detroit (Cryotherapy (PTC), Prednisone)
Completed
- Lung Cancer
- Metastatic Cancer
- Cryotherapy (PTC)
- Prednisone
-
Detroit, MichiganBarbara Ann Karmanos Cancer Institute
Oct 29, 2022
Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage I Lung Cancer AJCC v8 Trial (Nivolumab,
Withdrawn
- Lung Non-Small Cell Carcinoma
- +12 more
- Nivolumab
- Sapanisertib
- (no location specified)
May 24, 2022
Stage I Lung Non-Small Cell Cancer AJCC v7, Stage IA Lung Non-Small Cell Carcinoma AJCC v7, Stage IB Lung Non-Small Cell
Active, not recruiting
- Stage I Lung Non-Small Cell Cancer AJCC v7
- +6 more
- Carboplatin
- +5 more
-
Houston, TexasM D Anderson Cancer Center
Oct 24, 2022
Non-Squamous Non-Small Cell Lung Carcinoma, Stage I NSCLC, Stage IA Non-Small Cell Lung Carcinoma Trial in Abington,
Active, not recruiting
- Non-Squamous Non-Small Cell Lung Carcinoma
- +7 more
- Nivolumab
- +3 more
-
Abington, Pennsylvania
- +1 more
Sep 14, 2022
Lung Non-Small Cell Carcinoma, Stage I Lung Cancer AJCC v8, Stage IA1 Lung Cancer AJCC v8 Trial in Buffalo (Best Practice,
Not yet recruiting
- Lung Non-Small Cell Carcinoma
- +8 more
- Best Practice
- +2 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Dec 29, 2022
Lung Non-Small Cell Carcinoma, Stage I Lung Cancer AJCC v8, Stage II Lung Cancer AJCC v8 Trial (Pulmonary Artery-First Surgical
Not yet recruiting
- Lung Non-Small Cell Carcinoma
- +3 more
- Pulmonary Artery-First Surgical Technique
- Biospecimen Collection
- (no location specified)
Aug 15, 2022
Non-metastatic, Non-recurrent Lung and Esophageal Cancer
Recruiting
- Clinical Stage 0 Esophageal Adenocarcinoma AJCC v8
- +55 more
- Biospecimen Collection
- +3 more
-
Scottsdale, ArizonaMayo Clinic in Arizona
Jan 5, 2023
Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8, Stage IVA Lung Cancer AJCC v8 Trial in Houston
Recruiting
- Recurrent Lung Non-Small Cell Carcinoma
- +3 more
- Durvalumab
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Oct 10, 2022
NSCLC Trial in Shanghai (SBRT+LDRT, Toripalimab, Chemotherapy drug)
Recruiting
- NSCLC
- SBRT+LDRT
- +2 more
-
Shanghai, Shanghai, ChinaShanghai Chest Hospital
Apr 2, 2023
Lung Non-Small Cell Carcinoma, Stage I Lung Cancer AJCC v8, Stage IA1 Lung Cancer AJCC v8 Trial in Atlanta (Durvalumab,
Active, not recruiting
- Lung Non-Small Cell Carcinoma
- +9 more
-
Atlanta, GeorgiaEmory University Hospital/Winship Cancer Institute
Aug 22, 2022
Lung Non-Small Cell Carcinoma, Stage I Colorectal Cancer AJCC v8, Stage I Lung Cancer AJCC v8 Trial in Duarte (Quality-of-Life
Recruiting
- Lung Non-Small Cell Carcinoma
- +21 more
- Quality-of-Life Assessment
- +3 more
-
Duarte, CaliforniaCity of Hope Medical Center
Apr 5, 2022
Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial in
Not yet recruiting
- Metastatic Lung Non-Small Cell Carcinoma
- +2 more
- Cetuximab
- +2 more
-
Sacramento, CaliforniaUniversity of California Davis Comprehensive Cancer Center
Oct 2, 2023
Mesothelin Positive, Stage III NSCLC AJCC v7, Stage IIIA NSCLC AJCC v7 Trial in Phoenix, Jacksonville, Rochester (Anetumab
Terminated
- Mesothelin Positive
- +4 more
- Anetumab Ravtansine
- +2 more
-
Phoenix, Arizona
- +2 more
Jan 5, 2023
Locally Advanced Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8, Stage IIA Lung Cancer AJCC v8 Trial in Columbus
Recruiting
- Locally Advanced Lung Non-Small Cell Carcinoma
- +8 more
- Carboplatin
- +4 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Apr 18, 2022
Non Small Cell Lung Cancer, Secondary Lung Cancer Trial in Salt Lake City (Personalized Exercise Program)
Completed
- Non Small Cell Lung Cancer
- Secondary Lung Cancer
- Personalized Exercise Program
-
Salt Lake City, UtahHuntsman Cancer Institute
Aug 9, 2022